A Peek Into The Market Before The Trading Starts
Pre-open movers US stock futures are mostly flat this morning, as investors are awaiting jobs data. Futures for the Dow Jones Industrial Average dropped 4 points to 13,315.00 and S&P 500 index futures rose 0.40 points to 1,454.00. Nasdaq 100 futures gained 2.75 points to 2,728.25.
A Peek Into Global Markets European markets were lower today. The STOXX Europe 600 Index fell 0.24%, London's FTSE 100 Index dropped 0.13%, German DAX 30 Index declined 0.44% and French CAC 40 Index fell 0.27%.
Asian markets ended mixed, with Japan's Nikkei Stock Average rising 2.82%, China's Shanghai Composite gaining 0.35% and Australia's S&P/ASX 200 Index dropping 0.39%. Hong Kong's Hang Seng Index fell 0.29% and India's Sensex rose 0.10%.
Broker Recommendation Analysts at Deutsche Bank upgraded Johnson & Johnson (NYSE: JNJ) from “hold” to “buy.” The target price for Johnson & Johnson has been raised from $75 to $82.
Johnson & Johnson shares gained 0.52% to $71.11 in pre-market trading.
- Tranzyme Pharma (NASDAQ: TZYM) today announced the successful completion of its chemistry-based drug discovery collaboration with Bristol-Myers Squibb (NYSE: BMY). To read the full news, click here.
- Concord Medical Services (NYSE: CCM) announced today that it has closed the acquisition of 19.98% of indirect ownership of The University of Texas MD Anderson Cancer Center Proton Therapy Center. To read the full news, click here.
- UTStarcom Holdings (NASDAQ: UTSI) today announced the preliminary results of its previously announced tender offer for the purchase of up to 25,000,000 of its ordinary shares at a price of $1.20 per share, which expired at 5:00 P.M., New York City time, on Thursday, January 3, 2013. To read the full news, click here.
- PostRock Energy (NASDAQ: PSTR) today announced a $29.7 million capital budget for 2013. To read the full news, click here.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.